Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
Brain and Behavior · 2026
DOI: 10.1002/brb3.71418 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Behavior, 2026. Verfasst von Tianyi Gu und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Mitochondria. Die Arbeit nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Introduction
Alzheimer's disease (AD) is a complex neurodegenerative disorder whose pathogenesis involves multi‐level pathological alterations. This review aims to systematically elucidate the central role and multifaceted molecular mechanisms of mitochondrial dysfunction in the progression of AD.
Methods
A comprehensive analysis of the existing literature was conducted, synthesizing findings from studies investigating mitochondrial involvement in AD pathology. The review focused on key mechanistic pathways, including energy metabolism deficits, oxidative stress, synaptic damage, mitochondrial dynamics, mitochondria‐associated membranes (MAMs), mitophagy, and the gut–brain axis.
Results
The analysis revealed several critical mechanisms linking mitochondrial dysfunction to AD progression: (i) impaired mitochondrial energy metabolism, which establishes a causal relationship with oxidative stress and synaptic injury; (ii) dysregulation of mitochondrial fusion/fission dynamics, particularly the aberrant interactions of amyloid‐beta (Aβ) and p‐Tau with the fission protein Drp1 and the channel protein VDAC1; (iii) dysfunction of mitochondria‐associated membranes (MAMs); (iv) defective mitophagy involving both the PINK1/Parkin pathway and receptor‐mediated pathways; and (v) bidirectional crosstalk between mitochondria and the gut–brain axis. These interconnected pathways converge to amplify neuroinflammation and neuronal death.
Conclusion
Accumulated evidence positions mitochondrial dysfunction as a critical hub that integrates Aβ/Tau pathology, neuroinflammation, and neuronal loss, thereby perpetuating a self‐sustaining vicious cycle in AD. Targeting mitochondrial bioenergetics, dynamics, quality control, and the mitochondria–inflammation axis offers substantial therapeutic promise. Emerging small molecules such as SS31 and DDQ have demonstrated protective effects in preclinical models. Future investigations should prioritize mechanistic dissection and translational research to facilitate the clinical development of mitochondria‐targeted therapies for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Zitieren
APA
Gu, T., Guo, H., Guo, Z., & Hua, S. (2026). Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease. Brain and Behavior. https://doi.org/10.1002/brb3.71418
Vancouver
Gu T, Guo H, Guo Z, Hua S. Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease. Brain and Behavior. 2026. doi:10.1002/brb3.71418
BibTeX
@article{Gu2026,
author = {Gu, Tianyi and Guo, Hangyan and Guo, Zixin and Hua, Shengyu},
title = {Advances in the Core Role and Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease},
journal = {Brain and Behavior},
year = {2026},
doi = {10.1002/brb3.71418}
}
EUVIMED